Clinical Trial Update: A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of the nasal antiseptic PrevinC for reducing rhinitis risk in daycare workers; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Infections

Drugs mentioned

• PrevinC

Snippet

Sponsor: BioHealth Technologies Inc. | Conditions: Upper Respiratory Infections | Phase 4 | Status: COMPLETED